动脉粥样硬化斑块显像研究进展

张艳容

动脉粥样硬化斑块显像研究进展

张艳容

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 3: (109-113)

引用本文:

Citation:

动脉粥样硬化斑块显像研究进展

张艳容

430022 武汉, 华中科技大学同济医学院附属协和医院核医学科
中图分类号: R543.5;R817

The progress of research on atherosclerotic plaque imaging

ZHANG Yan-rong

Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
CLC number: R543.5;R817

摘要: 现有的一些用于动脉粥样硬化斑块诊断的检测方法如X线血管造影、血管内超声、光学相干体层扫描、B-型超声、电子束CT、核磁共振、拉曼光谱学检查和温度测量法等,在显示血管腔狭窄、管壁增厚、斑块体积以及斑块成分等方面各有其独特价值。但是,它们或因是创伤性检查、或因为检查本身的局限性(如只能显示钙化)、或不能早期发现以代谢紊乱为特征的病变,因而限制了它们在临床上的广泛应用。利用核素标记参与动脉粥样硬化的中间物质进行显像,可以精确、定量反映斑块成分和代谢情况,为无创伤性显示动脉粥样硬化斑块带来了希望,在疾病筛选、治疗决策、疗效观察以及随访研究上具有广阔的应用前景。
- 动脉粥样硬化斑块 /
- 体层摄影术 /
- 对比研究
Abstract: The available detecting methods such as X-ray angiography, IVUS, OCT, B-Mode ultrasound, EBCT, MRI, thermometry all have their special value in displaying vascular constriction, thickening and plaque volume when used in the diagnosis of atherosclerotic plaque. The extensive application on clinic is limited because of either the invasive feature, or the limitation that only can displaying calcification, or the method, which can't reveal the early stage lesion characterized by metabolism disorder. The imaging using the nuclide labeled substance participating in atherosclerosis can reveal plaque components and metabolism status precisely and quantificationally, which brings in promise of noninvasively displaying atherosclerotic plaque, and has expansive application foreground in disease screening, therapeutic decision-making, effect observation and follow-up study.
- atherosclerotic plaque /
- tomography /
- comparative study
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Zaman AG, Helft G, Worthley SG, et al. The role of plaque rupture and thrombosis in coronary artery disease[J].Atherosclerosis, 2000, 149(2):251-266.
[2]	Prati F, Arbustini E, Labellarte A, et al. Correlation between high frequency intravascular ultrasound and histomorphology in human coronary arteries[J]. Heart, 2001, 85(5):567.
[3]	Gronholdt ML. B-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis[J]. Neuroimag Clin N Am, 2002, 12(3):421-435.
[4]	Budoff MJ, Raggi P. Coronary artery disease progression assessed by electron-beam computed tomography[J]. Am J Cardiol, 2001, 88(2A):46E-50E.
[5]	Prigent FM, Steingart RM. Clinical value of electron-beam computed tomography in the diagnosis ang prognosis of coronary artery disease[J]. Curr Opin Cardiol, 1997, 12(6):561-565.
[6]	Schroeder S, Kopp AF, Ohnesorge B, et al. Virtual coronary angioscopy using multislice computed tomography[J]. Heart,2002, 87(3):205-209.
[7]	Shinnar M, Fallon JT, Wehrli S, et al. The diagnostic accuracy of ex vivo MR1 for human atherosclerotic plaque characterization[J]. Arterioscler Thromb Vasc Biol, 1999, 19(11):2756-2761.
[8]	Chan SK, Jaffer FA, Botnar RM, et al. Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden[J]. J Cardiovasc Magn Reson, 2001,3(4):331-338.
[9]	Yuan C, Kerwin WS, Ferguson MS, et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization[J]. J Magn Reson Imaging, 2002,15(1):62-67.
[10]	Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography[J]. Circulation, 2002,106(13):1640-1645.
[11]	Tearney GJ, Yabushita H, Houser SL, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography[J]. Circulation, 2003, 107(1):113.
[12]	Romer TJ, Brennan JF 3rd, Fitzmaurice M, et al.Histopathology of human coronary atherosclerosis by quantifying its chemical composition with Raman spectroscopy[J]. Circula-tion, 1998, 97(9):878-885.
[13]	van dc Poll SW, Romer TJ, Puppels GJ, et al. Imaging of atherosclerosis. Raman spectroscopy of atherosclerosis[J]. J Cardiovasc Risk, 2002, 9(5):255-261.
[14]	de Korte CL, Sierevogel MJ, Mastik F, et al. Identification of atherosclerotie plaque components with intravascular ultrasound elastography in vivo:a Yucatan pig study[J]. Circulation, 2002, 105(14):1627-1630.
[15]	Stefanadis C, Diamantopoulos L, Demellis J, et al. Heart production of atherosclerotic plaques and inflammation assessel by the acute phase proteins in acute coronary syndromes[J]. J Mol Cell Cardiol, 2000, 32(1):43-52.
[16]	Tsimikas S. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidationspecific antibodies[J]. Am J Cardiol, 2002, 90(10c):22L.
[17]	Zhang YX, Cao W, Wu ZJ. Radioiodine labeled SP-4 as an imaging agent for atherosclerotic plaques[J]. Nucl Scien Tech, 2000, 11(4):234-237.
[18]	Dinkelborg LM, Duda SH, Hanke H, et al. Molecular imaging of atherosclerosis using a technetium-99m-labeled endothelin derivative[J]. J Nucl Med, 1998, 39:1819-1822.
[19]	Lederman RJ, Raylman RR, Fisher SJ, et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose(FDG)[J]. Nucl Med Commun, 2001,22(7):747-753.
[20]	Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with[¹⁸F]-fluorodeoxyglucose positron emission tomography[J]. Circulation, 2002, 105(23):2708-2711.
[21]	Elmaleh DR, Narula J, Babich JW, et al. Rapid noninvasive detection of experimental atherosclerotic lesion with novel 99mTc-labeled diadenosine tetraphosphates[J]. Proc Natl Acad Sci USA, 1998, 95:691-695.

[1]	曹卫 , 张永学 . 动脉粥样硬化斑块核素显像研究进展. 国际放射医学核医学杂志, 1999, 23(5): 212-215.
[2]	万建美 , 范我 . 动脉粥样硬化斑块核素显像研究进展. 国际放射医学核医学杂志, 2007, 31(1): 17-20.
[3]	郭宵峰 , 刘建中 , 孙琦婷 . 肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究. 国际放射医学核医学杂志, 2015, 39(4): 277-281. doi: 10.3760/cma.j.issn.1673-4114.2015.04.001
[4]	张一秋 , 石洪成 . 肝细胞癌肿瘤新生血管影像学评价的研究进展. 国际放射医学核医学杂志, 2013, 37(1): 60-63. doi: 10.3760/cma.j.issn.1673-4114.2013.01.015
[5]	袁杰 , 刘兴党 , 韩梅 . SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用. 国际放射医学核医学杂志, 2013, 37(1): 30-33, 41. doi: 10.3760/cma.j.issn.1673-4114.2013.01.009
[6]	孙晓昕 , 田月琴 . PET-CT在冠状动脉疾病的临床应用. 国际放射医学核医学杂志, 2008, 32(3): 150-153.
[7]	杨宝军 , 李险峰 , 陆克义 , 赵德善 , 李思进 . ⁹⁹Tc^m-二亚乙基三胺五乙酸与⁹⁹Tc^m-奥曲肽眼眶显像在甲状腺相关性眼病中的对比研究. 国际放射医学核医学杂志, 2009, 33(1): 22-25. doi: 10.3760/cma.j.issn.1673-4114.2009.01.022
[8]	蔡晓君 , 秦颂兵 , 徐晓婷 , 周菊英 . PET-CT图像融合技术在非小细胞肺癌适形放射治疗中的应用价值. 国际放射医学核医学杂志, 2008, 32(3): 143-146.
[9]	叶慧 , 莫逸 , 谢爱民 , 彭翔 . ¹⁸F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
[10]	姚立新 , 刘彬彬 . 门控心肌灌注显像局部室壁运动异常判断冠状动脉狭窄程度的价值. 国际放射医学核医学杂志, 2007, 31(2): 90-93.

点击查看大图

计量

文章访问数: 1153
HTML全文浏览量: 170
PDF下载量: 2

动脉粥样硬化斑块显像研究进展

张艳容

430022 武汉, 华中科技大学同济医学院附属协和医院核医学科

收稿日期: 2003-09-24

关键词:

摘要: 现有的一些用于动脉粥样硬化斑块诊断的检测方法如X线血管造影、血管内超声、光学相干体层扫描、B-型超声、电子束CT、核磁共振、拉曼光谱学检查和温度测量法等,在显示血管腔狭窄、管壁增厚、斑块体积以及斑块成分等方面各有其独特价值。但是,它们或因是创伤性检查、或因为检查本身的局限性(如只能显示钙化)、或不能早期发现以代谢紊乱为特征的病变,因而限制了它们在临床上的广泛应用。利用核素标记参与动脉粥样硬化的中间物质进行显像,可以精确、定量反映斑块成分和代谢情况,为无创伤性显示动脉粥样硬化斑块带来了希望,在疾病筛选、治疗决策、疗效观察以及随访研究上具有广阔的应用前景。